{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T04:57:59Z","timestamp":1772341079651,"version":"3.50.1"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100006485","name":"National Institute for Genetic Engineering and Biotechnology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006485","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.intimp.2026.116358","type":"journal-article","created":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T04:25:49Z","timestamp":1770956749000},"page":"116358","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["An In Silico-Designed Chimeric Antigen Confers Broad Protection Against Major Diarrheal Pathogens (Shigella, ETEC, and EHEC) in Preclinical Models"],"prefix":"10.1016","volume":"174","author":[{"given":"Abbas","family":"Hajizade","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali Hatef","family":"Salmanian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Firouz","family":"Ebrahimi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayyoob","family":"Arpanaei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jafar","family":"Amani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.intimp.2026.116358_bb0005","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/S1473-3099(24)00691-1","article-title":"Global, regional, and national age-sex-specific burden of diarrhoeal diseases, their risk factors, and aetiologies, 1990\u20132021, for 204 countries and territories: a systematic analysis for the Global Burden of Disease Study 2021","volume":"25","author":"Kyu","year":"2025","journal-title":"Lancet Infect. Dis."},{"issue":"3","key":"10.1016\/j.intimp.2026.116358_bb0010","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1128\/CMR.18.3.465-483.2005","article-title":"Enterotoxigenic Escherichia coli in developing countries: epidemiology, microbiology, clinical features, treatment, and prevention","volume":"18","author":"Qadri","year":"2005","journal-title":"Clin. Microbiol. Rev."},{"issue":"10122","key":"10.1016\/j.intimp.2026.116358_bb0015","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/S0140-6736(17)33296-8","article-title":"Shigellosis","volume":"391","author":"Kotloff","year":"2018","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.intimp.2026.116358_bb0020","doi-asserted-by":"crossref","first-page":"538","DOI":"10.3345\/cep.2023.00668","article-title":"Risk factors of prolonged diarrhea in children under 2 years old","volume":"66","author":"Rahmat","year":"2023","journal-title":"Clinical and Experimental Pediatrics."},{"key":"10.1016\/j.intimp.2026.116358_bb0025","doi-asserted-by":"crossref","first-page":"1525838","DOI":"10.3389\/fnut.2025.1525838","article-title":"Contributing factors to acute malnutrition among children admitted to public health facilities in South West Ethiopia: a matched case\u2013control study","volume":"12","author":"Tamiru","year":"2025","journal-title":"Frontiers in Nutrition."},{"key":"10.1016\/j.intimp.2026.116358_bb0030","doi-asserted-by":"crossref","first-page":"348","DOI":"10.3389\/fpubh.2019.00348","article-title":"Diarrheagenic Escherichia coli pathotypes from children younger than 5 years in Kano State","volume":"7","author":"Saka","year":"2019","journal-title":"Nigeria. Frontiers in public health."},{"issue":"14","key":"10.1016\/j.intimp.2026.116358_bb0035","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1016\/j.vaccine.2006.12.028","article-title":"Analysis of strategies to successfully vaccinate infants in developing countries against enterotoxigenic E. coli (ETEC) disease","volume":"25","author":"Walker","year":"2007","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.intimp.2026.116358_bb0040","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3390\/toxins17020071","article-title":"Targeting Enterotoxins: Advancing Vaccine Development for Enterotoxigenic Escherichia coli ETEC","volume":"17","author":"Salvador-Erro","year":"2025","journal-title":"Toxins"},{"issue":"18","key":"10.1016\/j.intimp.2026.116358_bb0045","doi-asserted-by":"crossref","first-page":"9922","DOI":"10.3390\/ijms22189922","article-title":"Virulence factors of enteric pathogenic Escherichia coli: A review","volume":"22","author":"Pakbin","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.intimp.2026.116358_bb0050","doi-asserted-by":"crossref","first-page":"332","DOI":"10.3389\/fpubh.2017.00332","article-title":"Public health research resulting from one of the world\u2019s largest outbreaks caused by entero-hemorrhagic Escherichia coli in Germany 2011: a review","volume":"5","author":"K\u00f6ckerling","year":"2017","journal-title":"Front. Public Health"},{"issue":"4","key":"10.1016\/j.intimp.2026.116358_bb0055","doi-asserted-by":"crossref","first-page":"689","DOI":"10.3390\/vaccines8040689","article-title":"Characterization of shigetec, a novel live attenuated combined vaccine against shigellae and etec","volume":"8","author":"Harutyunyan","year":"2020","journal-title":"Vaccines"},{"issue":"4","key":"10.1016\/j.intimp.2026.116358_bb0060","first-page":"125","article-title":"Nanoparticles in vaccine development","volume":"1","author":"Hajizade","year":"2014","journal-title":"Journal of Applied Biotechnology Reports."},{"key":"10.1016\/j.intimp.2026.116358_bb0065","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.molimm.2019.09.018","article-title":"Designing a multi-epitope vaccine for cross-protection against Shigella spp: an immunoinformatics and structural vaccinology study","volume":"116","author":"Nosrati","year":"2019","journal-title":"Mol. Immunol."},{"issue":"1","key":"10.1016\/j.intimp.2026.116358_bb0070","doi-asserted-by":"crossref","first-page":"18","DOI":"10.52547\/vacres.8.1.18","article-title":"Design and Recombinant Expression of a multiepitope Vaccine Candidate Against Pathogenic Species of Shigella","volume":"8","author":"Namvar","year":"2021","journal-title":"Vaccine Research."},{"key":"10.1016\/j.intimp.2026.116358_bb0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2022.109464","article-title":"In silico design, production and immunization evaluation of a recombinant bivalent fusion protein candidate vaccine against E. coli O157: H7","volume":"114","author":"Samiei","year":"2023","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.intimp.2026.116358_bb0080","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.molimm.2019.09.015","article-title":"Entrapment of HETS recombinant protein onto PLGA and alginate NPs improves the immunogenicity of the protein against E. coli O157: H7","volume":"114","author":"Kordbacheh","year":"2019","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.intimp.2026.116358_bb0085","series-title":"ETEC Infection and Vaccine-Mediated Immunity","first-page":"1087","article-title":"Special Issue on Enterotoxigenic Escherichia coli (ETEC) Vaccines","author":"Cassels","year":"2024"},{"issue":"2","key":"10.1016\/j.intimp.2026.116358_bb0090","doi-asserted-by":"crossref","first-page":"344","DOI":"10.3390\/microorganisms11020344","article-title":"The diversity of Escherichia coli pathotypes and vaccination strategies against this versatile bacterial pathogen","volume":"11","author":"Pokharel","year":"2023","journal-title":"Microorganisms"},{"issue":"9","key":"10.1016\/j.intimp.2026.116358_bb0095","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1093\/infdis\/jiab462","article-title":"Critical needs in advancing Shigella vaccines for global health","volume":"225","author":"MacLennan","year":"2022","journal-title":"J. Infect. Dis."},{"issue":"5","key":"10.1016\/j.intimp.2026.116358_bb0100","first-page":"517","article-title":"An LTB-entrapped protein in PLGA nanoparticles preserves against enterotoxin of enterotoxigenic Escherichia coli","volume":"21","author":"Kordbacheh","year":"2018","journal-title":"Iranian Journal of Basic Medical Sciences."},{"issue":"8","key":"10.1016\/j.intimp.2026.116358_bb0105","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1016\/j.vaccine.2010.11.091","article-title":"Non-toxic derivatives of LT as potent adjuvants","volume":"29","author":"Da Hora","year":"2011","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.intimp.2026.116358_bb0110","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1128\/IAI.01394-13","article-title":"Characterization of heat-stable (STa) toxoids of enterotoxigenic Escherichia coli fused to double mutant heat-labile toxin peptide in inducing neutralizing anti-STa antibodies","volume":"82","author":"Ruan","year":"2014","journal-title":"Infect. Immun."},{"issue":"sup3","key":"10.1016\/j.intimp.2026.116358_bb0115","doi-asserted-by":"crossref","DOI":"10.1080\/21691401.2018.1529676","article-title":"EspA-loaded mesoporous silica nanoparticles can efficiently protect animal model against enterohaemorrhagic E. coli O157: H7","volume":"46","author":"Hajizade","year":"2018","journal-title":"Artif. Cells Nanomed. Biotechnol."},{"issue":"5","key":"10.1016\/j.intimp.2026.116358_bb0120","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1016\/j.vaccine.2010.11.035","article-title":"Enhanced immunogenicity of a novel Stx2Am-Stx1B fusion protein in a mice model of enterohemorrhagic Escherichia coli O157: H7 infection","volume":"29","author":"Cai","year":"2011","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.intimp.2026.116358_bb0125","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.biologicals.2013.03.002","article-title":"Molecular cloning and biologically active production of IpaD N-terminal region","volume":"41","author":"Hesaraki","year":"2013","journal-title":"Biologicals"},{"issue":"12","key":"10.1016\/j.intimp.2026.116358_bb0130","doi-asserted-by":"crossref","first-page":"4470","DOI":"10.1128\/IAI.00859-13","article-title":"Characterization of a novel fusion protein from IpaB and IpaD of Shigella spp. and its potential as a pan-Shigella vaccine","volume":"81","author":"Martinez-Becerra","year":"2013","journal-title":"Infect. Immun."},{"issue":"1","key":"10.1016\/j.intimp.2026.116358_bb0135","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s40259-023-00627-0","article-title":"Outer membrane vesicle vaccine platforms","volume":"38","author":"Micoli","year":"2024","journal-title":"BioDrugs"},{"key":"10.1016\/j.intimp.2026.116358_bb0140","doi-asserted-by":"crossref","first-page":"823","DOI":"10.3389\/fmicb.2015.00823","article-title":"A combined vaccine approach against Vibrio cholerae and ETEC based on outer membrane vesicles","volume":"6","author":"Leitner","year":"2015","journal-title":"Front. Microbiol."},{"issue":"1","key":"10.1016\/j.intimp.2026.116358_bb0145","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00203-025-04562-2","article-title":"Microbial membrane vesicles and the intestinal epithelium: a crosstalk in health and disease","volume":"208","author":"Abubakari","year":"2026","journal-title":"Arch. Microbiol."},{"issue":"7","key":"10.1016\/j.intimp.2026.116358_bb0150","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.3390\/microorganisms13071579","article-title":"Rotavirus Reverse Genetics Systems and Oral Vaccine Delivery Vectors for Mucosal Vaccination","volume":"13","author":"Wang","year":"2025","journal-title":"Microorganisms"},{"issue":"2","key":"10.1016\/j.intimp.2026.116358_bb0155","first-page":"229","article-title":"Design and in silico analysis of pentavalent chimeric antigen against three enteropathogenic bacteria: enterotoxigenic E. coli, enterohemorragic E. coli and Shigella. Bioscience Biotechnology Research","volume":"9","author":"Hajizade","year":"2016","journal-title":"Communications"},{"issue":"6","key":"10.1016\/j.intimp.2026.116358_bb0160","doi-asserted-by":"crossref","first-page":"718","DOI":"10.2174\/1381612824666180131121940","article-title":"Recombinant protein expression in Escherichia coli (E. coli): what we need to know","volume":"24","author":"Hayat","year":"2018","journal-title":"Curr. Pharm. Des."},{"issue":"5","key":"10.1016\/j.intimp.2026.116358_bb0165","doi-asserted-by":"crossref","first-page":"221","DOI":"10.4172\/2157-7013.1000221","article-title":"An overview of the parameters for recombinant protein expression in Escherichia coli","volume":"6","author":"Joseph","year":"2015","journal-title":"J Cell Sci Ther."},{"issue":"1","key":"10.1016\/j.intimp.2026.116358_bb0170","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-019-53200-7","article-title":"Optimization of culture conditions for the expression of three different insoluble proteins in Escherichia coli","volume":"9","author":"Guti\u00e9rrez-Gonz\u00e1lez","year":"2019","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.intimp.2026.116358_bb0175","article-title":"Dialysis and concentration of protein solutions. Current Protocols","volume":"10","author":"Andrew","year":"2001","journal-title":"Toxicology"},{"issue":"5","key":"10.1016\/j.intimp.2026.116358_bb0180","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1038\/nprot.2008.48","article-title":"A protocol for determination of anticardiolipin antibodies by ELISA","volume":"3","author":"Pierangeli","year":"2008","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.intimp.2026.116358_bb0185","series-title":"Bioassay and related methods. Modern food microbiology","first-page":"257","author":"Jay","year":"2005"},{"issue":"9","key":"10.1016\/j.intimp.2026.116358_bb0190","doi-asserted-by":"crossref","first-page":"2951","DOI":"10.1128\/JCM.00860-12","article-title":"Multicenter evaluation of a sequence-based protocol for subtyping Shiga toxins and standardizing Stx nomenclature","volume":"50","author":"Scheutz","year":"2012","journal-title":"J. Clin. Microbiol."},{"issue":"5698","key":"10.1016\/j.intimp.2026.116358_bb0195","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1126\/science.1102610","article-title":"Structural insights into the assembly of the type III secretion needle complex","volume":"306","author":"Marlovits","year":"2004","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.intimp.2026.116358_bb0200","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1111\/mmi.12124","article-title":"S higella IpaD has a dual role: signal transduction from the type III secretion system needle tip and intracellular secretion regulation","volume":"87","author":"Roehrich","year":"2013","journal-title":"Mol. Microbiol."},{"issue":"6325","key":"10.1016\/j.intimp.2026.116358_bb0205","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1038\/351371a0","article-title":"Crystal structure of a cholera toxin-related heat-labile enterotoxin from E. coli","volume":"351","author":"Sixma","year":"1991","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.intimp.2026.116358_bb0210","doi-asserted-by":"crossref","first-page":"202","DOI":"10.3390\/toxins14030202","article-title":"STxB as an antigen delivery tool for mucosal vaccination","volume":"14","author":"Tartour","year":"2022","journal-title":"Toxins"},{"issue":"9","key":"10.1016\/j.intimp.2026.116358_bb0215","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.3390\/cells12091291","article-title":"Engineered synthetic STxB for enhanced cytosolic delivery","volume":"12","author":"Hadjerci","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.intimp.2026.116358_bb0220","article-title":"A novel mechanism for protein delivery by the type 3 secretion system for extracellularly secreted proteins","volume":"8(2):10.1128\/mbio","author":"Tejeda-Dominguez","year":"2017","journal-title":"MBio"},{"issue":"3","key":"10.1016\/j.intimp.2026.116358_bb0225","doi-asserted-by":"crossref","first-page":"35","DOI":"10.3390\/antib9030035","article-title":"Antibodies inhibiting the type III secretion system of Gram-negative pathogenic bacteria","volume":"9","author":"Hotinger","year":"2020","journal-title":"Antibodies"},{"issue":"10\u201311","key":"10.1016\/j.intimp.2026.116358_bb0230","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/j.micinf.2009.04.024","article-title":"Enterohemorrhagic Escherichia coli trivalent recombinant vaccine containing EspA, intimin and Stx2 induces strong humoral immune response and confers protection in mice","volume":"11","author":"Gu","year":"2009","journal-title":"Microbes Infect."},{"issue":"27","key":"10.1016\/j.intimp.2026.116358_bb0235","doi-asserted-by":"crossref","first-page":"3949","DOI":"10.1016\/j.vaccine.2018.05.059","article-title":"Efficacy of a recombinant Intimin, EspB and Shiga toxin 2B vaccine in calves experimentally challenged with Escherichia coli O157: H7","volume":"36","author":"Martorelli","year":"2018","journal-title":"Vaccine"},{"issue":"22","key":"10.1016\/j.intimp.2026.116358_bb0240","doi-asserted-by":"crossref","first-page":"5293","DOI":"10.1002\/j.1460-2075.1994.tb06863.x","article-title":"The secretion of the Shigella flexneri Ipa invasins is activated by epithelial cells and controlled by IpaB and IpaD","volume":"13","author":"Menard","year":"1994","journal-title":"EMBO J."},{"issue":"18","key":"10.1016\/j.intimp.2026.116358_bb0245","doi-asserted-by":"crossref","first-page":"5899","DOI":"10.1128\/jb.175.18.5899-5906.1993","article-title":"Nonpolar mutagenesis of the ipa genes defines IpaB, IpaC, and IpaD as effectors of Shigella flexneri entry into epithelial cells","volume":"175","author":"Menard","year":"1993","journal-title":"J. Bacteriol."},{"issue":"3","key":"10.1016\/j.intimp.2026.116358_bb0250","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1128\/IAI.73.3.1432-1440.2005","article-title":"IpaD of Shigella flexneri is independently required for regulation of Ipa protein secretion and efficient insertion of IpaB and IpaC into host membranes","volume":"73","author":"Picking","year":"2005","journal-title":"Infect. Immun."},{"issue":"5","key":"10.1016\/j.intimp.2026.116358_bb0255","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0008326","article-title":"SipD and IpaD induce a cross-protection against Shigella and Salmonella infections","volume":"14","author":"Jneid","year":"2020","journal-title":"PLoS Negl. Trop. Dis."},{"issue":"1","key":"10.1016\/j.intimp.2026.116358_bb0260","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S1773-2247(14)50005-6","article-title":"Novel intranasal vaccine delivery system by chitosan nanofibrous membrane containing N-terminal region of IpaD antigen as a nasal Shigellosis vaccine, Studies in Guinea pigs","volume":"24","author":"Jahantigh","year":"2014","journal-title":"J. Drug Delivery Sci. Technol."},{"key":"10.1016\/j.intimp.2026.116358_bb0265","article-title":"An in-silico-designed multiepitope vaccine candidate can efficiently protect mice against pathogenic species of Shigella","volume":"113905","author":"Vansofla","year":"2025","journal-title":"J. Immunol. Methods"}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S156757692600202X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S156757692600202X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T04:20:12Z","timestamp":1772338812000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S156757692600202X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":53,"alternative-id":["S156757692600202X"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2026.116358","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An In Silico-Designed Chimeric Antigen Confers Broad Protection Against Major Diarrheal Pathogens (Shigella, ETEC, and EHEC) in Preclinical Models","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2026.116358","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"116358"}}